187 related articles for article (PubMed ID: 30506945)
1. Comorbid immune-mediated diseases in inflammatory bowel disease: a nation-wide population-based study.
Park SW; Kim TJ; Lee JY; Kim ER; Hong SN; Chang DK; Yang M; Kim S; Shin MH; Kim YH
Aliment Pharmacol Ther; 2019 Jan; 49(2):165-172. PubMed ID: 30506945
[TBL] [Abstract][Full Text] [Related]
2. The impact of co-existing immune-mediated diseases on phenotype and outcomes in inflammatory bowel diseases.
Conway G; Velonias G; Andrews E; Garber JJ; Yajnik V; Ananthakrishnan AN
Aliment Pharmacol Ther; 2017 Mar; 45(6):814-823. PubMed ID: 28105709
[TBL] [Abstract][Full Text] [Related]
3. Incidence of psoriasiform diseases secondary to tumour necrosis factor antagonists in patients with inflammatory bowel disease: a nationwide population-based cohort study.
Bae JM; Lee HH; Lee BI; Lee KM; Eun SH; Cho ML; Kim JS; Park JM; Cho YS; Lee IS; Kim SW; Choi H; Choi MG
Aliment Pharmacol Ther; 2018 Jul; 48(2):196-205. PubMed ID: 29869804
[TBL] [Abstract][Full Text] [Related]
4. [Two-year incidence of new immune-mediated inflammatory diseases in patients with inflammatory bowel disease: A study in the AQUILES cohort].
Marín-Jiménez I; Gisbert JP; Pérez-Calle JL; García-Sánchez V; Tabernero S; García-Vicuña R; Romero C; Juliá B; Vanaclocha F; Cea-Calvo L;
Gastroenterol Hepatol; 2015 Dec; 38(10):569-74. PubMed ID: 25983283
[TBL] [Abstract][Full Text] [Related]
5. Risk of Neurodegenerative Diseases in Patients with Inflammatory Bowel Disease: A Nationwide Population-based Cohort Study.
Kim GH; Lee YC; Kim TJ; Kim ER; Hong SN; Chang DK; Kim YH
J Crohns Colitis; 2022 Mar; 16(3):436-443. PubMed ID: 34499125
[TBL] [Abstract][Full Text] [Related]
6. Incidence and temporal trends of co-occurring personality disorder diagnoses in immune-mediated inflammatory diseases.
Blaney C; Sommer J; El-Gabalawy R; Bernstein C; Walld R; Hitchon C; Bolton J; Sareen J; Patten S; Singer A; Lix L; Katz A; Fisk J; Marrie RA;
Epidemiol Psychiatr Sci; 2020 Jan; 29():e84. PubMed ID: 31915099
[TBL] [Abstract][Full Text] [Related]
7. Risk of incident Mycobacterium tuberculosis infection in patients with inflammatory bowel disease: a nationwide population-based study in South Korea.
Hong SN; Kim HJ; Kim KH; Han SJ; Ahn IM; Ahn HS
Aliment Pharmacol Ther; 2017 Jan; 45(2):253-263. PubMed ID: 27933686
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of idiopathic pulmonary fibrosis in inflammatory bowel disease: A nationwide study.
Kim J; Chun J; Lee C; Han K; Choi S; Lee J; Soh H; Choi K; Park S; Kang EA; Lee HJ; Im JP; Kim JS
J Gastroenterol Hepatol; 2020 Feb; 35(2):249-255. PubMed ID: 31420894
[TBL] [Abstract][Full Text] [Related]
9. Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization.
Weng X; Liu L; Barcellos LF; Allison JE; Herrinton LJ
Am J Gastroenterol; 2007 Jul; 102(7):1429-35. PubMed ID: 17437504
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory bowel disease increases the risks of deep vein thrombosis and pulmonary embolism in the hospitalized patients: a nationwide cohort study.
Chung WS; Lin CL; Hsu WH; Kao CH
Thromb Res; 2015 Mar; 135(3):492-6. PubMed ID: 25596768
[TBL] [Abstract][Full Text] [Related]
11. Increased end-stage renal disease risk in patients with inflammatory bowel disease: A nationwide population-based study.
Park S; Chun J; Han KD; Soh H; Choi K; Kim JH; Lee J; Lee C; Im JP; Kim JS
World J Gastroenterol; 2018 Nov; 24(42):4798-4808. PubMed ID: 30479466
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory Bowel Disease Phenotype in Pediatric Primary Sclerosing Cholangitis.
Lascurain L; Jensen MK; Guthery SL; Holmen J; Deneau M
Inflamm Bowel Dis; 2016 Jan; 22(1):146-50. PubMed ID: 26619054
[TBL] [Abstract][Full Text] [Related]
13. Comorbid Diabetes in Inflammatory Bowel Disease Predicts Adverse Disease-Related Outcomes and Infectious Complications.
Kumar A; Teslova T; Taub E; Miller JD; Lukin DJ
Dig Dis Sci; 2021 Jun; 66(6):2005-2013. PubMed ID: 32617771
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory bowel diseases increase future ischemic stroke risk: a Taiwanese population-based retrospective cohort study.
Huang WS; Tseng CH; Chen PC; Tsai CH; Lin CL; Sung FC; Kao CH
Eur J Intern Med; 2014 Jul; 25(6):561-5. PubMed ID: 24906568
[TBL] [Abstract][Full Text] [Related]
15. Risk of Malignancy in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients.
Khan N; Vallarino C; Lissoos T; Darr U; Luo M
Drugs Aging; 2017 Nov; 34(11):859-868. PubMed ID: 29170864
[TBL] [Abstract][Full Text] [Related]
16. Increased Risk of Inflammatory Bowel Disease Among Patients With Ankylosing Spondylitis: A 13-Year Population-Based Cohort Study.
Wang S; Tsou HK; Chiou JY; Wang YH; Zhang Z; Wei JC
Front Immunol; 2020; 11():578732. PubMed ID: 33123163
[TBL] [Abstract][Full Text] [Related]
17. 5-aminosalicylic acids and the risk of renal disease: a large British epidemiologic study.
Van Staa TP; Travis S; Leufkens HG; Logan RF
Gastroenterology; 2004 Jun; 126(7):1733-9. PubMed ID: 15188168
[TBL] [Abstract][Full Text] [Related]
18. Association of inflammatory bowel disease with asthma risk: A nationwide cohort study.
Peng YH; Liao WC; Su CH; Chen HJ; Hsia TC; Chu CC; Liu CJ; Kao CH
Allergy Asthma Proc; 2015; 36(5):e92-8. PubMed ID: 26314810
[TBL] [Abstract][Full Text] [Related]
19. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease.
García Rodríguez LA; Ruigómez A; Panés J
Gastroenterology; 2006 May; 130(6):1588-94. PubMed ID: 16697722
[TBL] [Abstract][Full Text] [Related]
20. Long-term risk of acute coronary syndrome in patients with inflammatory bowel disease: a 13-year nationwide cohort study in an Asian population.
Tsai MS; Lin CL; Chen HP; Lee PH; Sung FC; Kao CH
Inflamm Bowel Dis; 2014 Mar; 20(3):502-7. PubMed ID: 24412991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]